| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-911 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate |
1988-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e40f675c3295c8f923f2e9e933fd91c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43c4e96bd1f770b63413c541f8482d5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_039019f291bf399eeab5db61f32f09ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587d901d1550fc8518a7472a55c1a5c2 |
| publicationDate |
1989-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H01163180-A |
| titleOfInvention |
Process for antifungal fermentation product |
| abstract |
NEW MATERIAL: The antibiotic compound represented by formula and named as 1-[(4R,5R)-4,5-dihydroxy-N 2 -(10,12-dimethyl-1-oxotetradecil)-L- ornithine]-5-(treo-3-hydroxy-1-glutamin)-ethynocandin B. n USE: Having very high activity against human fungal infection substantially with no toxicity and no undesirable effect. n PROCESS: The strain ATCC20868 of fungus has not been fixed in a nutritional medium is aerobically cultured until a substantial quantity of antifungal activity is generated preferably at about 20 to 40°C for about 3 to 30 days. Then the compound of formula is obtained by recovering the active component from the medium preferably by an alcohol, condensing thereof, extracting or distributing thereof in a specific solvent such as an oxygenated organic solvent not be mixed with water, again condensing and separating by a chromatography at least once. n COPYRIGHT: (C)1989,JPO |
| priorityDate |
1987-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |